These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 9414020)

  • 41. Striatal c-fos induction by drugs and stress in neonatally dopamine-depleted rats given nigral transplants: importance of NMDA activation and relevance to sensitization phenomena.
    Snyder-Keller AM
    Exp Neurol; 1991 Aug; 113(2):155-65. PubMed ID: 1831151
    [TBL] [Abstract][Full Text] [Related]  

  • 42. DA uptake sites, D1 and D2 receptors, D2 and preproenkephalin mRNAs and Fos immunoreactivity in rat striatal subregions after partial dopaminergic degeneration.
    Chritin M; Blanchard V; Raisman-Vozari R; Feuerstein C; Agid Y; Javoy-Agid F; Savasta M
    Eur J Neurosci; 1996 Dec; 8(12):2511-20. PubMed ID: 8996800
    [TBL] [Abstract][Full Text] [Related]  

  • 43. D1 dopamine receptor agonist-induced Fos-like immunoreactivity occurs in basal forebrain and mesopontine tegmentum cholinergic neurons and striatal neurons immunoreactive for neuropeptide Y.
    Robertson GS; Staines WA
    Neuroscience; 1994 Mar; 59(2):375-87. PubMed ID: 7911982
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Substantia nigra D1 receptors and stimulation of striatal cholinergic interneurons by dopamine: a proposed circuit mechanism.
    Abercrombie ED; DeBoer P
    J Neurosci; 1997 Nov; 17(21):8498-505. PubMed ID: 9334422
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The 5-HT1A and 5-HT2A/2C receptor antagonists WAY-100635 and ritanserin do not attenuate D-fenfluramine-induced fos expression in the brain.
    Javed A; Van de Kar LD; Gray TS
    Brain Res; 1998 Apr; 791(1-2):67-74. PubMed ID: 9593827
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Interactions between D1 and muscarinic receptors in the induction of striatal c-fos in rats depleted of dopamine as neonates.
    Sandstrom MI; Sarter M; Bruno JP
    Brain Res Dev Brain Res; 1996 Oct; 96(1-2):148-58. PubMed ID: 8922677
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Dopaminergic basis for the facilitation of brain stimulation reward by the NMDA receptor antagonist, MK-801.
    Olds ME
    Eur J Pharmacol; 1996 Jun; 306(1-3):23-32. PubMed ID: 8813611
    [TBL] [Abstract][Full Text] [Related]  

  • 48. L-DOPA produces strong induction of c-fos messenger RNA in dopamine-denervated cortical and striatal areas of the common marmoset.
    Svenningsson P; Gunne L; Andren PE
    Neuroscience; 2000; 99(3):457-68. PubMed ID: 11029538
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Role of NMDA glutamate receptors in regulating D2 dopamine-dependent Fos induction in the rat striatopallidal pathway.
    Pollack AE; Bird JL; Lambert EB; Florin ZP; Castellar VL
    Brain Res; 1999 Feb; 818(2):543-7. PubMed ID: 10082844
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Dopamine and glutamate agonists stimulate neuron-specific expression of Fos-like protein in the striatum.
    Berretta S; Robertson HA; Graybiel AM
    J Neurophysiol; 1992 Sep; 68(3):767-77. PubMed ID: 1359024
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Dopaminergic and glutamatergic mechanisms mediate the induction of FOS-like protein by cocaethylene.
    Horowitz JM; DiPirro JM; Kristal MB; Torres G
    Brain Res Bull; 1997; 42(5):393-8. PubMed ID: 9092881
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Stimulatory role of dopamine on fibroblast growth factor-2 expression in rat striatum.
    Roceri M; Molteni R; Fumagalli F; Racagni G; Gennarelli M; Corsini G; Maggio R; Riva M
    J Neurochem; 2001 Feb; 76(4):990-7. PubMed ID: 11181818
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Prior D1 dopamine receptor stimulation is required to prime D2-mediated striatal Fos expression in 6-hydroxydopamine-lesioned rats.
    Pollack AE; Yates TM
    Neuroscience; 1999; 94(2):505-14. PubMed ID: 10579212
    [TBL] [Abstract][Full Text] [Related]  

  • 54. N-methyl-D-aspartate receptor blockade attenuates D1 dopamine receptor modulation of neuronal activity in rat substantia nigra.
    Huang KX; Bergstrom DA; Ruskin DN; Walters JR
    Synapse; 1998 Sep; 30(1):18-29. PubMed ID: 9704877
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Regulation of c-Fos and NGF1-A by antidepressant treatments.
    Morinobu S; Strausbaugh H; Terwilliger R; Duman RS
    Synapse; 1997 Apr; 25(4):313-20. PubMed ID: 9097389
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Induction of c-fos in rat brain by acute cocaine and fenfluramine exposure: a comparison study.
    Torres G; Rivier C
    Brain Res; 1994 May; 647(1):1-9. PubMed ID: 8069690
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Cortical ionotropic glutamate receptor antagonism protects against methamphetamine-induced striatal neurotoxicity.
    Gross NB; Duncker PC; Marshall JF
    Neuroscience; 2011 Dec; 199():272-83. PubMed ID: 21946008
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Time course of striatal changes induced by 6-hydroxydopamine lesion of the nigrostriatal pathway, as studied by combined evaluation of rotational behaviour and striatal Fos expression.
    Labandeira-Garcia JL; Rozas G; Lopez-Martin E; Liste I; Guerra MJ
    Exp Brain Res; 1996 Feb; 108(1):69-84. PubMed ID: 8721156
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The atypical dopamine D1 receptor agonist SKF 83959 induces striatal Fos expression in rats.
    Wirtshafter D; Osborn CV
    Eur J Pharmacol; 2005 Dec; 528(1-3):88-94. PubMed ID: 16324697
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Local release of GABAergic inhibition in the motor cortex induces immediate-early gene expression in indirect pathway neurons of the striatum.
    Berretta S; Parthasarathy HB; Graybiel AM
    J Neurosci; 1997 Jun; 17(12):4752-63. PubMed ID: 9169535
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.